Some GLP-1 drugs are also used for obesity treatment because they help reduce appetite, slow gastric emptying, and support weight loss
Quick Answer: Significant weight loss alone, regardless of mechanism, can restore ovulation and menstruation in women with obesity-related anovulation In obesity, this extra estrogen contributes to anovulation, irregular cycles, and increased endometrial growth
Studies comparing the combined therapy to individual medications found greater reductions against SGLT2is than GLP1-RAs
Eli Lilly's retatrutide may be the first real test of whether healthcare boards are prepared for multi-indication valueand the governance frameworks it demands
For high-stakes cases (recent cardiovascular event, severe obstructive sleep apnea, advanced metabolic disease), referencing the specific clinical trial evidence supporting use in that population strengthens the submission